Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients.
about
NASH Cirrhosis - the New Burden in Liver Transplantation: How Should It Be Managed?Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: Magnetic Resonance Imaging Is an Effective, Non-invasive Method to Evaluate Changes in the Liver Fat Fraction.Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease.Acid sphingomyelinase deficiency in Western diet-fed mice protects against adipocyte hypertrophy and diet-induced liver steatosis.Circulating level of CTRP1 in patients with nonalcoholic fatty liver disease (NAFLD): is it through insulin resistance?Chronic angiotensin AT2R activation prevents high-fat diet-induced adiposity and obesity in female mice independent of estrogen.Higher Thyroid-Stimulating Hormone, Triiodothyronine and Thyroxine Values Are Associated with Better Outcome in Acute Liver Failure.The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controllNormal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort.The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis.Associations of insulin resistance, inflammation and liver synthetic function with very low-density lipoprotein: The Cardiovascular Health Study.Role of Serum Biomarkers in Early Detection of Non-Alcoholic Steatohepatitis and Fibrosis in West Virginian Children.Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction.Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitisSPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease.Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1.TRAIL Deletion Prevents Liver, but Not Adipose Tissue, Inflammation during Murine Diet-Induced Obesity.Mixed lineage kinase 3 connects hepatocellular lipotoxicity with macrophage chemotaxis.Fatty liver is associated with blood pathways of inflammatory response, immune system activation and prothrombotic state in Young Finns Study.Meta-Analysis of Adiponectin as a Biomarker for the Detection of Metabolic Syndrome
P2860
Q28079900-FC9D6B1E-FE81-4DDF-BAFB-C7ACC356C0E9Q31153508-6613DF4E-0FE1-435C-BE59-03734A2CE183Q33586821-5623507D-DAF2-48EC-A7EA-05071D507058Q33600495-316B8748-C2EC-4BF4-8928-84873327E579Q35576521-17D4EE84-0D04-4183-8ED2-411640F6AF0DQ35624869-BA093799-E6CF-4991-997F-5F8979A5932FQ35684045-E8EB9E4F-DC17-4AE5-922E-212F501D1B62Q35914728-834D348C-99AF-4777-8CE2-25330FC2DF39Q35948791-A44FB192-A592-4CC9-9FE8-6477B23B7470Q36329899-D3673B19-869E-4CE5-9CCA-D70E4AEF2377Q36599680-BBC213DD-23D3-4A98-BA0E-38A2F2D785EAQ36900196-6934E1F9-0A67-44BA-B1A2-08935D4366E3Q37689828-6AB790DF-3F31-42BF-960C-D9A6147C70ADQ38570247-064A4162-F4A0-41EE-9D03-850B3B0D1176Q38699261-EA9F13C1-548B-44D8-8266-23B405D5B852Q49287362-2AFE6905-659A-4A61-AFBE-23853680C669Q51544078-55B0A705-64C7-45DB-A4C3-347063805C8FQ52745207-5C200AC3-E2A6-406B-8277-DC621B16BFC1Q54235434-9E341FF8-ABC2-4BFB-AF79-00849A25E89BQ55647258-6CD8B514-7397-4F89-A134-A83BAB37D821Q58553707-B02AEE44-5986-489F-B8DA-4DDC83AB7EB6
P2860
Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Adipocyte cell size, free fatt ...... on in severely obese patients.
@ast
Adipocyte cell size, free fatt ...... on in severely obese patients.
@en
type
label
Adipocyte cell size, free fatt ...... on in severely obese patients.
@ast
Adipocyte cell size, free fatt ...... on in severely obese patients.
@en
prefLabel
Adipocyte cell size, free fatt ...... on in severely obese patients.
@ast
Adipocyte cell size, free fatt ...... on in severely obese patients.
@en
P2093
P50
P1433
P1476
Adipocyte cell size, free fatt ...... on in severely obese patients.
@en
P2093
Alexander Wree
Ariel E Feldstein
Harald Köfeler
Hideo A Baba
Martin Schlattjan
Michael Trauner
Tatjana Stojakovic
Thierry Claudel
P304
P356
10.1016/J.METABOL.2014.09.001
P577
2014-09-06T00:00:00Z